RU EN

Naryzhnaya N.V.

Doctor of Medical Sciences

Laboratory of Experimental Cardiology

H-index: RSCI 12, Scopus 12, Web of Science 10

Articles

  1. Naryzhnaya N.V., Maslov L.N., Derkachev I.A., Ma H., Zhang Y., Prasad N.R., Singh N., Fu F., Pei J., Sarybaev A., Sydykov A. The effect of an adaptation to hypoxia on cardiac tolerance to ischemia/reperfusion. Journal of Biomedical Research 2023;37(4):230-254.
  2. Maslov L.N., Naryzhnaya N.V., Popov S.V., Mukhomedzyanov A.V., Derkachev I.A., Kurbatov B.K., Krylatov A.V., Fu Feng, Pei J., Ryabov V.V., Vyshlov E.V., Gusakova S.V., Boshchenko A.A., Sarybaev A. A historical literature review of coronary microvascular obstruction and intra-myocardial hemorrhage as functional/structural phenomena. Journal of Biomedical Research 2023;37(4):268-289.
  3. Maslov L.N., Naryzhnaya N.V., Sirotina M.A., Mukhomedzyanov A.V., Kurbatov B.K., Boshchenko A.A., Ma Huijie, Zhang Yi, Fu Feng, Pei J., Azev V.N., Pereverzev V.A. Do reactive oxygen species damage or protect the heart in ischemia and reperfusion? Analysis of experimental and clinical data. Journal of Biomedical Research 2023;37(4):255-267.
  4. Maslov L.N., Popov S.V., Naryzhnaya N.V., Mukhomedzyanov A.V., Kurbatov B.K., Derkachev I.A., Boshchenko A.A., Rajendra Prasad N., Ma H., Zhang Yi, Safianova G.Z., Fu F., Pei J-M.. KATP channels are regulators of programmed cell death and targets for the creation of novel drugs against ischemia/reperfusion cardiac injury. Fundamental and Clinical Pharmacology 2023;37(6):1 020-1 049.
  5. Kologrivova I.V., Naryzhnaya N.V., Koshelskaya O.A., Suslova T.E., Kravchenko E.S., Kharitonova O.A., Evtushenko V.V., Boshchenko A.A. Association of Epicardial Adipose Tissue Adipocytes Hypertrophy with Biomarkers of Low‐Grade Inflammation and Extracellular Matrix Remodeling in Patients with Coronary Artery Disease. Biomedicines 2023;11(2):1-17.
  6. Maslov L.N., Popov S.V., Naryzhnaya N.V., Mukhomedzyanov A.V., Kurbatov B.K., Derkachev I.A., Boshchenko A.A., Khaliulin I., Prasad N.R., Singh N., Degterev A., Tomilova E.A., Sapozhenkova E.V. The regulation of necroptosis and perspectives for the development of new drugs preventing ischemic/reperfusion of cardiac injury. Apoptosis 2022;27(9-10):697-719.
  7. Maslov L.N., Popov S.V., Mukhomedzyanov A.V., Naryzhnaya N.V., Voronkov N.S., Ryabov V.V., Boshchenko A.A., Khaliulin I., Prasad R.N., Fu F., Pei J.-M., Logvinov S.V., Oeltgen P.R. Reperfusion Cardiac Injury: Receptors and the Signaling Mechanisms. Current Cardiology Reviews 2022;18(5):63-79.
  8. Нарыжная Н.В., Логвинов С.В., Курбатов Б.К., Мухомедзянов А.В., Сиротина М.А., Чепелев С.Н, Висмонт Ф.И., Маслов Л.Н. Эффективность дистантного ишемического посткондиционирования миокарда у крыс с индуцированным метаболическим синдромом зависит от уровня лептина. Весці Нацыянальнай акадэміі навук Беларусі. Серыя медыцынскіх навук 2022;19(1):38-47.
  9. Naryzhnaya N.V., Koshelskaya O.A., Kologrivova I.V., Suslova T.E., Kharitonova O.A., Andreev S.L., Gorbunov A.S., Kurbatov B.K., Boshchenko A.A. Production of Reactive Oxygen Species by Epicardial Adipocytes Is Associated with an Increase in Postprandial Glycemia, Postprandial Insulin, and a Decrease in Serum Adiponectin in Patients with Severe Coronary Atherosclerosis. Biomedicines 2022;10(8):1-19.
  10. Попов С.В., Прокудина Е.С., Мухомедзянов А.В., Нарыжная Н.В., Ma Huijie, Zurmanova Jitka M., van der Ven Peter F. M., Маслов Л.Н. Cardioprotective and Vasoprotective Effects of Corticotropin-Releasing Hormone and Urocortins: Receptors and Signalling. Journal of Cardiovascular Pharmacology and Therapeutics 2021;26(6):575-584.
  11. Popov S.V., Maslov L.N., Naryzhnaya N.V., Mukhomedzyanov A.V., Krylatov A.V., Tsibulnikov S.Y., Ryabov V.V., Cohen M.V., Downey J.M. The role of pyroptosis in ischemic and reperfusion injury of the heart. Journal of Cardiovascular pharmacology and therapeutics 2021;26(6):562-574.
  12. Kurbatov B.K., Prokudina E.S., Maslov L.N., Naryzhnaya N.V., Logvinov S.V., Gorbunov A.S., Mukhomedzyanov A.V., Krylatov A.V., Voronkov N.S., Sementsov A.S., Zavadovsky K.V., Saushkin V.V., Nagarajan R.P., Oeltgen P.R. The role of adrenergic receptors, muscarinic receptors, glucocorticoids, reactive oxygen species in stress-induced cardiac injury. Pflügers Archiv: European Journal of Physiology 2021;473(10):1 641-1 655.
  13. Prokudina E.S., Kurbatov B.K., Zavadovsky K.V., Vrublevsky A.V., Naryzhnaya N.V., Lishmanov Yu.B., Maslov L.N., Oeltgen P.R. Takotsubo syndrome: clinical manifestations, etiology and pathogenesis. Current Cardiology Reviews 2021;17(2):188-203.
  14. Naryzhnaya N.V., Ma H., Maslov L.N. The involvement of protein kinases in the cardioprotective effect of chronic hypoxia. Physiological research / Academia Scientiarum Bohemoslovaca 2020;69(6):933-945.
  15. Maslov L.N., Naryzhnaya N.V., Boshchenko A.A., Popov S.V., Ivanov V.V., Oeltgen P.R. Is oxidative stress of adipocytes a cause or a consequence of the metabolic syndrome?. Journal of Clinical and Translational Endocrinology 2019;15:1-5.
  16. Naryzhnaya N.V., Maslov L.N., Lishmanov Y.B., Nesterov E.A., Yaggi A.S., Suleiman M.S. The mitochondrial permeability transition pore – a regulator of the resistance of the heart to reperfusion. Neuroscience and Behavioral Physiology 2019;49(8):943-953.
  17. Naryzhnaya N.V., Maslov L.N., Oeltgen P.R. Pharmacology of mitochondrial permeability transition pore inhibitors. Drug Development Research 2019;80(8):1 013-1 030.
  18. Prokudina E.S., Maslov L.N., Naryzhnaya N.V., Tsibulnikov S.Yu., Lishmanov Yu.B., Madias J.E., Oeltgen P.R. Cardioprotective Properties of Opioid Receptor Agonists in Rats with Stress-Induced Cardiac Injury. Physiological research / Academia Scientiarum Bohemoslovaca 2019;68:375-384.
  19. Prokudina E.S., Naryzhnaya N.V., Kolar F., Mukhomedzyanov A.V., Gorbunov A.S., Zhang Y., Jaggi A.S., Tsibulnikov S.Y., Nesterov E.A., Lishmanov Yu.B., Suleiman M.-S., Oeltgen P.R., Maslov L.N. Effect of chronic continuous normobaric hypoxia on functional state of cardiac mitochondria and tolerance of isolated rat heart to ischemia and reperfusion: Role of µ and δ2 opioid receptors. Physiological research / Academia Scientiarum Bohemoslovaca 2019;68(6):909-920.
  20. Tsibulnikov S.Y., Maslov L.N., Naryzhnaya N.V., Ivanov V.V., Bushov Y.V., Voronkov N.S., Jaggi A.S., Zhang Yi, Oeltgen P.R. Impact of cold adaptation on cardiac tolerance to ischemia/reperfusion. Role of glucocorticoid and thyroid hormones. General Physiology and Biophysics 2019;38(3):245-251.
  21. Naryzhnaya N.V., Khaliulin I., Lishmanov Y.B., Suleiman M.-Saaden, Tsibulnikov S.Y., Kolar F., Maslov L.N. Participation of Opioid Receptors in the Cytoprotective Effect of Chronic Normobaric Hypoxia. Physiological research / Academia Scientiarum Bohemoslovaca 2019;68:245-253.
  22. Tsibulnikov S.Y., Maslov L.N., Naryzhnaya N.V., Ma H., Lishmanov Y.B., Oeltgen P.R., Garlid K. Role of protein kinase C, PI3 kinase, tyrosine kinases, NO-synthase, KATP channels and MPT pore in the signaling pathway of the cardioprotective effect of chronic continuous hypoxia. General Physiology and Biophysics 2018;37(5):537-547.
  23. Maslov L.N., Khaliulin I., Zhang Y., Krylatov A.V., Naryzhnaya N.V., Mechoulam R., De Petrocellis L., Downey J.M. Prospects for creation of cardioprotective drugs based on cannabinoid receptor agonists. Journal of Cardiovascular Pharmacology and Therapeutics 2016;21(3):262-272.
  24. Maslov L.N., Khaliulin I., Oeltgen P.R., Naryzhnaya N.V., Pei J.-M., Brown S.A., Lishmanov Y.B., Downey J.M. Prospects of creation of cardioprotective and antiarrhythmic drugs based on opioid receptor agonists. Medicinal Research Reviews 2016;36(5):871-923.
  25. Maslov L.N., Naryzhnaya N.V., Podoksenov Yu.K., Mrochek A.G., Gorbunov A.S., Tsibul'nikov S.Yu. Opioids as triggers of the adaptive phenomenon of ischemic preconditioning of the heart. Neuroscience and Behavioral Physiology 2016;46(3):319-327.
  26. Maslov L.N., Naryzhnaya N.V., Prokudina E.S., Kolar F., Gorbunov A.S., Zhang Y., Wang H., Tsibulnikov S.Yu., Portnichenko A.G., Lasukova T.V., Lishmanov Y.B. Preserved cardiac mitochondrial function and reduced ischemia/reperfusion injury afforded chronic continuous hypoxia: role of opioid receptors. Clinical and Experimental Pharmacology and Physiology 2015;42:496-501.